|
|
Credits: 0.5 CME / 0.5 CNE
|
Expires: 8/2012
|
|
According to the World Health Organization, there are more than 30 unique types of lymphomas. In this CME activity, blood oncology expert Charles M. Farber, MD, PhD, discusses the different types of hematologic malignancies and how clinicians should evolve therapeutic approaches based on factors such as tumor classification and patient response.
|
|
|
|
|
Credits: 0.5 CME / 0.6 CNE
|
Expires: 4/2012
|
|
Novel combination regimens have had a profound effect on the treatment of patients with multiple myeloma. In this interactive learning activity, Charles M. Farber, MD, PhD, draws on his clinical experience to discuss current treatment strategies for treating multiple myeloma patients, the clinical benefits of using novel agents in treatment regimens, and the place for novel agents in transplantation protocols.
|
|
|
|
|
|
Credits: 1.0 CME / 1.0 CNE
|
Expires: 4/2012
|
|
Multiple myeloma remains an incurable disease for the majority of patients. The goal of maintenance therapy is to help patients achieve and maintain a durable remission. In this learning activity, Ashraf Badros, MD, discusses the role of maintenance therapy when treating multiple myeloma and examines recommended treatment strategies for various patient cohorts.
|
|
|
|
|
|
Credits: 1.0 CME / 1.0 CNE
|
Expires: 3/2012
|
|
Multiple myeloma is an incurable hematologic malignancy characterized by a highly variable duration of response and long-term outcomes, with treatment relapse remaining a key issue. In this learning activity, blood oncology expert Sagar Lonial, MD, offers his expertise on individualized treatment strategies for multiple myeloma patients and compares clinical evidence for utilizing novel agent-based regimens in different patient cohorts. This activity also features additional commentary from Charise Gleason, MSN, NP-C, AOCNP.
|
|
|
|
|
|
Credits: 0.5 CME / 0.5 CNE
|
Expires: 2/2012
|
|
Multiple myeloma patients can develop painful bone lesions, and despite their treatment, most lesions fail to heal completely. In this podcast learning activity, Adam D. Cohen, MD, discusses the available diagnostic imaging modalities used in the detection and management of bone disease in multiple myeloma patients, and examines the clinical practice guidelines for the use of bisphosphonates and novel therapeutic agents in treating myeloma bone disease.
|
|
|
|
|